C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor

Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
10/2004
10/28/2004	WO2003020954A3 205p1b5 in treatment and detection of cancer
10/28/2004	WO2003014704A3 Rapid and specific detection of campylobacter
10/28/2004	WO2002088322A3 Cell adhesion and extracellular matrix proteins
10/28/2004	WO2001098460A3 Fusion proteins of mycobacterium tuberculosis
10/28/2004	WO2001081540A3 Growth factor which acts through erb b-4 rtk
10/28/2004	US20040216194 Tagetes erecta marigolds with altered carotenoid compositions and ratios
10/28/2004	US20040216193 Methods for stabilizing and controlling apomixis
10/28/2004	US20040216191 Using DNA immobilized, glycerol-free metal microparticles to bombardment plant tissue in osmotic nutrient broth; tissue engineering and heterologous gene expression
10/28/2004	US20040216190 Expression vector for transfer and generation of freeze, herbicide, drought, heat and disease resistant plants; tissue engineering
10/28/2004	US20040216189 Maize chloroplast aldolase promoter compositions and methods for use thereof
10/28/2004	US20040216188 Isoforms of strach branching enzyme II (SBE-IIA and SBE-IIB) from wheat
10/28/2004	US20040216187 Preparation of deallergenized proteins and permuteins
10/28/2004	US20040216186 AXMI-006, a delta-endotoxin gene and methods for its use
10/28/2004	US20040216185 Transforming plant tissue with nucleotide sequences coding enzyme associated with fatty acid biosynthesis for use in modifying plant oil characteristics, polyketide engineering and designing anti-cancer and anti-tuberculosis agents
10/28/2004	US20040216184 Novel plant promoters for use in early seed development
10/28/2004	US20040216183 Signal transduction stress-related proteins and methods of use in plants
10/28/2004	US20040216182 Generation of plants with improved pathogen resistance and drought tolerance
10/28/2004	US20040216181 Dna construct to confer multiple traits on plants
10/28/2004	US20040216180 Nucleic acids encoding linked chromo/fluorescent domains and methods for using the same
10/28/2004	US20040216179 Recombinant plasmid expressing two fluorescence genes
10/28/2004	US20040216178 Knockout expression vector which targets preferential ocogenic gene for use as tool in treatment of cell proliferative diseases
10/28/2004	US20040216177 Congenic rats containing a mutant GPR10 gene
10/28/2004	US20040216176 Compositions and methods for characterizing and regulating Wnt pathways
10/28/2004	US20040215251 Genetic modification of targeted regions of the cardiac conduction system
10/28/2004	US20040215011 Using matrix comprised of biopolymers to isolate DNA/RNA sequences from cell lysates
10/28/2004	US20040215008 Production of proteins by autoproteolytic cleavage
10/28/2004	US20040215006 Oligonucleotide sequences for treatment and prevention of cell proliferative and skin disorders; gene expression inhibition; antisense agents
10/28/2004	US20040214999 Novel compounds for chemiluminescense procedures
10/28/2004	US20040214996 Multimeric peptides/immunoglobulins for use in the treatment of bone disorders
10/28/2004	US20040214995 Melanoma antigens and their use in diagnostic and therapeutic methods
10/28/2004	US20040214994 Genetically engineered immunoglobulin specific for hepatitis helicase for use in prevention and treatment of infection; immunotherapy
10/28/2004	US20040214990 Transmembrane protein differentially expressed in cancer
10/28/2004	US20040214788 by administering an antagonist against one or more of the vitamin binding proteins riboflavin carrier protein, retinol binding protein, and folic acid binding protein
10/28/2004	US20040214776 (truncated GDNF) proteins that promote dopamine uptake by dopaminergic cells and promote the survival of nerve cells
10/28/2004	US20040214762 administering serine protease inhibitors and optionally in combination with substance P or peptide hormones, for prophylaxis of nervous system disorders, autoimmune disorders and tissue regeneration processes, such as wound healing
10/28/2004	US20040214760 Inhibition pf protein-phosphatases for the treatment of heart failure
10/28/2004	US20040214759 Compositions and methods of use for a fibroblast growth factor
10/28/2004	US20040214757 nuclear proteins which binds, in a sequence specific manner, to regulatory sequences of immunoglobulin light or heavy chain genes; bioassay
10/28/2004	US20040214332 Stable, multipotent transgenic nervous system progenitor tissue for treatment and prevention of neurodegenerative disorders
10/28/2004	US20040214331 Transforming and propagating viral-like particle in cells; for use as tools in prevention and treatment of viral infection; viricides and genetic vaccines
10/28/2004	US20040214330 Methods and means for obtaining modified phenotypes
10/28/2004	US20040214329 Circular nucleic acid vectors, and methods for making and using the same
10/28/2004	US20040214328 Multifunctional molecular complexes for gene transfer to cells
10/28/2004	US20040214325 Oligonucleotide sequences for use in controlling apolipoprotein expression and treatment of cardiovascular disorders; gene expression inhibition
10/28/2004	US20040214318 Viral expression vector comprising enhancing regulatory sequences for use as heterologous gene transfer and expression tool; in vitro transcription/translation systems
10/28/2004	US20040214308 Gamma-glutamylcystein-producing yeast and method of screening the same
10/28/2004	US20040214304 Microbiocidal gastrointestinal microorganism for use in food processing and the prevention of infection; bacteriocin
10/28/2004	US20040214303 Complex
10/28/2004	US20040214302 Detection of nucleic acids by type-specific hybrid capture method
10/28/2004	US20040214295 Using Flavobacterium lutescens cells; piperidine-6-carboxylic acid dehydrogenase; genetic engineering
10/28/2004	US20040214294 Process for the production of L-amino acids using strains of the enterobacteriaceae family
10/28/2004	US20040214292 Method of producing template DNA and method of producing protein in cell-free protein synthesis system using the same
10/28/2004	US20040214290 Plant artificial chromosomes, uses thereof and methods of preparing plant artificial chromosomes
10/28/2004	US20040214288 Methods of generating high-production of antibodies from hybridomas created by in vitro immunization
10/28/2004	US20040214287 Modified cytokines generated via site directed mutagenesis for use as long acting, user-friendly, therapeutic proteins; cachexia treatment and bioreactors
10/28/2004	US20040214286 Comprises nucleotide sequences coding cell growth factors for use in developing modulators for treatment of cell proliferative, arthritic, skin and vision defects; immunotherapy
10/28/2004	US20040214285 HIV-specific fusion proteins and therapeutic and diagnostic methods for use
10/28/2004	US20040214284 Isolated peptides which bind to MHC class II molecules, and uses thereof
10/28/2004	US20040214283 Isolated human nuclear hormone receptors, nucleic acid molecules encoding human nuclear hormone receptors, and uses thereof
10/28/2004	US20040214281 Methods and compositions for high level expression of a heterologous protein with poor codon usage
10/28/2004	US20040214277 Methods and compositions for polypeptide engineering
10/28/2004	US20040214276 host cells containing expression systems for production of nucleotide diphosphate 6-deoxy-mycarose; polyketides
10/28/2004	US20040214275 Von willebrand factor (vmf)-cleaving enzyme
10/28/2004	US20040214274 via direct fermentation of cyclic depsipeptide; introducing gene involved in biosynthetic pathway from chorismic acid to p-aminophenylpyruvic acid (biosynthesis gene) into a phenylalanine auxotrophic host; antihelmintic; nematocides
10/28/2004	US20040214273 Method for secretory production of glycoprotein having human-type sugar chain using plant cell
10/28/2004	US20040214272 Nucleic acid molecules and other molecules associated with plants
10/28/2004	US20040214271 Process for producing recombined protein
10/28/2004	US20040214270 Isocitrate dehydrogenase, gene thereof, and use of the same in the treatment of obesity, hyperlipidemia, and fattly liver in lipid biosynthesis
10/28/2004	US20040214269 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/28/2004	US20040214268 Comprises nucleotide sequences coding membrane proteins for stimulating release of tumor necrosis factor and/or cell proliferation of chondrocytes by contacting blood with polypeptide; cancer diagnosis
10/28/2004	US20040214267 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/28/2004	US20040214265 Comprises nucleotide sequences coding membrane proteins for stimulating release of tumor necrosis factor and/or cell proliferation of chondrocytes by contacting blood with polypeptide; cancer diagnosis
10/28/2004	US20040214264 Comprises nucleotide sequences coding dimethylarginine dimethylaminohydrolase-1 protein (DDAH1) for use in identifying modulators for treatment of diabetes and cardiovascular disorders
10/28/2004	US20040214263 Transgenic cells comprising antisense and ribozyme sequences for use in treatment of infections, autoimmune and proliferative disorders
10/28/2004	US20040214261 culturing genetically modified microorganism containing polyglutamyl hydrolase (from rodents, mammals, or humans) activity to enhance generation of monoglutamyl folate; food processing; dairy products
10/28/2004	US20040214247 Comprises immunoglobulin which binds to tumor specific epitope and inhibits binding of matrix protein/collagen/gelatin complexes; immunotherapy and antitumor agents
10/28/2004	US20040214246 Monoclonal antibodies specific to pro-prostate specific antigen (PROPSA) for use as component of bioassy for detection of cancer
10/28/2004	US20040214245 Diagnostic and therapeutic use of antibodies against the urokinase receptor
10/28/2004	US20040214242 Using imunoglobulin specific for single stranded phage coat fusion protein to detect variability in sequences coding target protein in artificially generated genome pools
10/28/2004	US20040214235 Immunoglobulin specific to tumor necrosis factor -related apoptosis-inducing ligand (TRAIL) for use in the prevention and treatment of cancer; immnotherapy
10/28/2004	US20040214227 Luminescent fusion protein for use as tool in monitoring biopolymer interactions; bioassay for protein interaction
10/28/2004	US20040214224 Identifying two or more of a plurality of sequences differing by one or more single-base changes, insertions, deletions, or translocations in a plurality of target nucleotide sequences using one or more primary oligonucleotide primer groups and cyclic replication
10/28/2004	US20040214222 Gene targeting methods and vectors
10/28/2004	US20040214219 Nucleotide sequences which code for the tal gene
10/28/2004	US20040214218 inclusion or cluster compounds used for DNA compaction and gene therapy
10/28/2004	US20040214216 Nucleotide sequences coding cysteinyl-tRNA synthetase for use in identifying modulators protein synthesis; enzyme inhibitors and herbicides
10/28/2004	US20040214214 Nucleotide sequences coding obesity polypeptide for use in the diagnosis and treatment of viral, cell proliferative weight control and eating disorders
10/28/2004	US20040214209 Receptor protein for use as tool in kit for detection of immunoglobulins
10/28/2004	US20040214206 Method of designing multifunctional base sequence
10/28/2004	US20040214205 Semiconductor comprising DNA constituents for use in genomic analysis; biochips
10/28/2004	US20040214202 Comprises nucleotide sequences coding n-acetylgalactosamine transferase polypeptide for use in identifying modulators for treatment of cell proliferative disorders; pharmacogenomics
10/28/2004	US20040214201 Comprises nucleotide sequence coding polyphenol oxidase for use in identifying modulators which inhibit browning, increase polyphenols and enhance fruit and vegetable flavor
10/28/2004	US20040214198 Allele-targeted RNA interference
10/28/2004	US20040214197 Method of preparing polynucleotide fragments for use in shuffling, and shuffling of same
10/28/2004	US20040214195 Loci for idiopathic generalized epilepsy, mutations thereof and method using same to assess, diagnose, prognose or treat epilepsy
10/28/2004	US20040214194 Using sequence reorganization/rearrangement to generate polymerases with enhanced activity
10/28/2004	US20040214192 Diagnosing allergies via measuring expression of nuclear orphan receptor (NOR-1 receptor) gene; identifying modulators for treating atopic dermatitis
10/28/2004	US20040214191 Nucleotide sequences coding ganosine triphosphatase ligand for use in diagnosis and treatment of cell proliferative disorders
10/28/2004	US20040214190 Mammalian c-type lectins
10/28/2004	US20040214189 Hematopoietic stem cell proliferation regulators and polynucleotides encoding the same

1 ... 2147 2148 2149 2150 2151 2152 2153 2154 2155 2156 2157 2158 2159 2160 2161 2162 2163 2164 2165 2166 2167 ... 4023